First report of sweating associated with topical beta-blocker therapy.
Schmutz
J L
JL
Barbaud
A
A
Reichert
S
S
Vasse
J P
JP
Trechot
P
P
D000287:Administration, Topical; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000009:adverse effects*; D000368:Aged; D002354:Carteolol / Q000008:administration & dosage / Q000009:adverse effects*; D005902:Glaucoma, Open-Angle / Q000188:drug therapy; D006801:Humans; D008297:Male; D009883:Ophthalmic Solutions; D013546:Sweating / Q000187:drug effects*
D000319:Adrenergic beta-Antagonists; D009883:Ophthalmic Solutions; D002354:Carteolol